GRI Bio, Inc. (GRI)
1.80
-0.03
(-1.64%)
USD |
NASDAQ |
Nov 12, 16:00
1.80
0.00 (0.00%)
After-Hours: 18:31
GRI Bio Market Cap : 3.935M for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 11, 2026 | 4.001M |
| November 10, 2026 | 4.132M |
| November 09, 2026 | 3.738M |
| November 06, 2026 | 4.110M |
| November 05, 2026 | 3.388M |
| November 04, 2026 | 3.126M |
| November 03, 2026 | 3.367M |
| November 02, 2026 | 3.192M |
| October 30, 2026 | 3.345M |
| October 29, 2026 | 3.432M |
| October 28, 2026 | 3.552M |
| October 27, 2026 | 3.454M |
| October 26, 2026 | 3.279M |
| October 23, 2026 | 3.170M |
| October 22, 2026 | 3.104M |
| October 21, 2026 | 3.214M |
| October 20, 2026 | 3.192M |
| October 19, 2026 | 3.170M |
| October 16, 2026 | 3.017M |
| October 15, 2026 | 3.060M |
| October 14, 2026 | 3.060M |
| October 13, 2026 | 3.388M |
| October 12, 2026 | 3.432M |
| October 09, 2026 | 3.804M |
| October 08, 2026 | 3.673M |
| Date | Value |
|---|---|
| October 07, 2026 | 4.044M |
| October 06, 2026 | 4.154M |
| October 05, 2026 | 4.176M |
| October 02, 2026 | 4.285M |
| October 01, 2026 | 4.285M |
| September 30, 2026 | 4.219M |
| September 29, 2026 | 4.372M |
| September 28, 2026 | 4.591M |
| September 25, 2026 | 4.482M |
| September 24, 2026 | 4.569M |
| September 23, 2026 | 4.700M |
| September 22, 2026 | 4.482M |
| September 21, 2026 | 4.241M |
| September 18, 2026 | 4.219M |
| September 17, 2026 | 4.022M |
| September 16, 2026 | 3.957M |
| September 15, 2026 | 3.979M |
| September 14, 2026 | 4.132M |
| September 11, 2026 | 4.154M |
| September 10, 2026 | 4.241M |
| September 09, 2026 | 3.935M |
| September 08, 2026 | 4.372M |
| September 04, 2026 | 6.296M |
| September 03, 2026 | 5.006M |
| September 02, 2026 | 4.372M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.132B |
| Alnylam Pharmaceuticals, Inc. | 20.96B |
| Anika Therapeutics, Inc. | 185.37M |
| Savara, Inc. | 968.08M |
| Vericel Corp. | 2.930B |
Market Cap Related Metrics
| Price to Book Value | 0.3828 |
| Price | 1.80 |
| Earnings Yield | -2.43K% |